Mutations in the GNPTAB gene cause Mucolipidosis II (MLII) and III, two human lysosomal storage
disorders characterized by a defective form of N-acetylglucosamine-1-phosphotransferase (GlcNAc-1-
PTase). This enzyme catalyzes the synthesis of Mannose-6-Phosphate (M6P) residues on newly
synthesized lysosomal hydrolases, and these residues serve as targeting signals to lysosomes. Hence, in
MLII or III, defective M6P synthesis results in acid hydrolase hypersecretion and accumulation of their
substrates in lysosomes. Intriguingly, fibroblasts isolated from MLII patients exhibit more resistance to
several cytotoxic agents. Since it has been reported that the frequency of GNPTAB variants is increased in
breast and uterine cancers, we wondered whether GlcNAc-1-PTase inactivation in cancer cells could also
confer them protection against induced cell death. To test this hypothesis, control and GNPTAB-KO HeLa
cells were treated with different concentrations of chloroquine and doxorubicin. Taken together, the results
of MTT assays and phase contrast microscopy analyses support that GNPTAB-KO HeLa cells are more
resistant to the cytotoxic effect of those molecules. Moreover, caspase 3 activation upon treatment with
doxorubicin was found lower in GNPTAB-KO cells compared to control cells, suggesting that the KO cells
are more specifically resistant to caspase-dependent apoptosis. Lastly, we detected sustained levels of NF-
κB in the KO cells after treatment, which might be among the mechanisms that confers them apoptosis
resistance. Other mechanisms, including increased trapping of doxorubicin and chloroquine in their
lysosomes, are also considered. Taken together, our findings raise the possibility that deregulation of M6P
synthesis in cancer cells, and thus of acid hydrolases sorting to lysosomes, may confer resistance to some
chemotherapeutic agents.
Date of Award | 27 Mar 2023 |
---|
Original language | English |
---|
Awarding Institution | |
---|
Supervisor | Marielle Boonen (Supervisor) |
---|
Do HeLa cells knock-out for GNPTAB, which codes for α and β subunits of N-acetylglucosamine- 1-phosphotransferase, exhibit resistance to cytotoxic agents?
OOSTVOGELS, N. (Author). 27 Mar 2023
Student thesis: Master types › Master in Pharmaceutical Sciences, research focus